http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : Yu-Hsiu (검색결과 38 건)
- 무료
- 기관 내 무료
- 유료
-
DESTINATION BRAND COOLNESS: CONCEPTUALIZATION AND SCALE DEVELOPMENT
Hsiu-Yu Teng,Cheng-Hsien Tsai,Chia-Wen Hung,Hui-Chen Hung 글로벌지식마케팅경영학회 2023 Global Marketing Conference Vol.2023 No.07
Destination branding has become an important trend in modern tourism. The development of destination brands has become a strategic tool worldwide because of the growing competition between destinations. In recent years, many tourist destinations have combined unique, creative, and attractive elements to transform themselves into “cool” tourist destinations. Destination brand coolness refers to tourists’ subjective and positive perception of tourist destinations and their beliefs that the destination brand offer distinctive, novel characteristics and attributes that the visitors are attracted to. Creating destination brand coolness can help tourist destinations differentiate themselves from their competitive counterparts, thereby attracting tourists. However, no study has conceptualized the construct of destination brand coolness, let alone developing scales that measure destination brand coolness.
-
-
Yu-Hsiu Juan,Wei-Chou Chang,Chih-Yung Yu,Hsian-He Hsu,Guo-Shu Huang,De-Chuan Chan,Chang-Hsien Liu,Ho-Jui Tung 연세대학교의과대학 2011 Yonsei medical journal Vol.52 No.4
Purpose: To assess the clinical manifestations and multidetector-row computed tomography (MDCT) findings of afferent loop syndrome (ALS) and to determine the role of MDCT on treatment decisions. Materials and Methods: From January 2004 to December 2008, 1,100 patients had undergone gastroenterostomy reconstruction in our institution. Of these, 22 (2%) patients were diagnosed as ALS after surgery that included Roux-en-Y gastroenterotomy (n=9), Billroth-II gastrojejunostomy (n=7), and Whipple’s operation (n=6). Clinical manifestations and MDCT features of these patients were recorded and statistically analyzed. The presumed etiologies of obstruction shown on the MDCT were correlated with clinical information and confirmed by surgery or endoscopic biopsy. Results: The most common clinical symptom was acute abdominal pain, presenting in 18 patients (82%). We found that a fluid-filled C-shaped afferent loop in combination with valvulae conniventes projecting into the lumen was the most common MDCT features of ALS. Malignant causes of ALS, such as local recurrence and carcinomatosis, are the most common etiologies of obstruction. These etiologies and associated complications can be predicted 100% by MDCT. Conclusion: Our results suggest that MDCT is a reliable modality for assessing the etiologies of ALS and guiding treatment decisions.
-
Impact of Adjuvant Chemotherapy in Elderly Breast Patients in Taiwan, A Hospital-Based Study
Lee, Hsiu Chuan,Chen, Wei Yu,Huang, Wen Tsung,Cheng, Kuo Chen,Tian, Yu Feng,Ho, Chung Han,Tsao, Chao Jung,Feng, Yin Hsun Asian Pacific Journal of Cancer Prevention 2016 Asian Pacific journal of cancer prevention Vol.17 No.10
Purpose: Decisions as to whether to provide adjuvant treatment in older breast cancer patients remains challenging. Side effects of chemotherapy have to be weighed against life expectancy, comorbidities, functional status, and frailty. To aid decision-making, we retrospectively analyzed 110 women with breast cancer treated with a curative intention from 2006 to 2012. Survival data with clinical and pathological parameters were evaluated to address the role of adjuvant chemotherapy in this study population. Method: A total of 110 elderly (>70 years) patients that received mastectomy at two hospitals in Taiwan were observed retrospectively for a medium of 51 months. After mastectomy, patients received conservative treatment or adjuvant chemotherapy, or hormone therapy following clinical guidelines or physician's preference. Data were collected from the cancer registry system. Results: Median age at diagnosis was 75.7 years. Thirty-five percent of patients received adjuvant chemotherapy, these having a significantly younger age ($mean=74.0{\pm}5.3$ vs $77.5{\pm}5.3$, p<0.001) and higher tumor staging (p=0.003) compared with their non-chemotherapy counterparts.Five-year overall survival was non-significantly higher in patients who received adjuvant chemotherapy (with chemotherapy 64.2% vs without chemotherapy 62.6%, p=0.635), while five-year recurrence free survival was non-significantly lower (with chemotherapy 64.1% vs without chemotherapy 90.5%, p=0.80). Conclusions: In this analysis, adjuvant chemotherapy tended to be given to patients with a younger age and higher tumor staging at our institute. It was not associated with any statistically significant improvement in survival and recurrence rate. Until age specific recommendations are available, physicians must use their clinical judgment and assess the tumor biology with the patient's comorbidities to make the best choice. Clinical trials focusing on this critical issue are warranted.
-
-
Combined Assessment of Serum Alpha-Synuclein and Rab35 is a Better Biomarker for Parkinson’s Disease
Hung-Li Wang,Chin-Song Lu,Tu-Hsueh Yeh,Yu-Ming Shen,Yi-Hsin Weng,Ying-Zu Huang,Rou-Shayn Chen,Yu-Chuan Liu,Yi-Chuan Cheng,Hsiu-Chen Chang,Ying-Ling Chen,Yu-Jie Chen,Yan-Wei Lin,Chia Chen Hsu,Huang-Li 대한신경과학회 2019 Journal of Clinical Neurology Vol.15 No.4
Background and Purpose It is essential to develop a reliable predictive serum biomarker for Parkinson’s disease (PD). Te accumulation of alpha-synuclein (αSyn) and up-regulated expression of Rab35 participate in the etiology of PD. Te purpose of this investigation was to determine whether the combined assessment of serum αSyn and Rab35 is a useful predictive biomarker for PD. Methods Serum levels of αSyn or Rab35 were determined in serum samples from 59 sporadic PD patients, 19 progressive supranuclear palsy (PSP) patients, 20 multiple system atrophy (MSA) patients, and 60 normal controls (NC). Receiver operating characteristics (ROC) curves were calculated to determine the diagnostic accuracy of αSyn or/and Rab35 in discriminating PD patients from NC or atypical parkinsonian patients. Results The levels of αSyn and Rab35 were increased in PD patients. The serum level of Rab35 was positively correlated with that of αSyn in PD patients. Compared to analyzing αSyn or Rab35 alone, the combined analysis of αSyn and Rab35 produced a larger area under the ROC curve and performed better in discriminating PD patients from NC, MSA patients, or PSP patients. When age was dichotomized at 55, 60, 65, or 70 years, the combined assessment of αSyn and Rab35 for classifying PD was better in the group below the cutof age than in the group above the cutof age. Conclusions Combined assessment of serum αSyn and Rab35 is a better biomarker for discriminating PD patients from NC or atypical parkinsonian patients, and is a useful predictive biomarker for younger sporadic PD patients.
-
Yu-Chi Li,Chung-Han Ho,Hsiu-Hung Wang 한국간호과학회 2017 Asian Nursing Research Vol.11 No.3
Purpose: This study aimed to explore the protective factors of demoralization in cancer patients via investigation of cancer patients' demographic and disease characteristics. Methods: This was a cross-sectional descriptive study. We used a structured questionnaire, which contained items on demographic and disease characteristics, as well as the Demoralization Scale Mandarin Version (DS-MV), with a cutoff of 30 or more indicating high demoralization. Data were analyzed with age-matched and gender-matched conditional logistic regression analysis. For the study, 428 questionnaires were delivered and 411 were recovered. After being age-matched and gender-matched, 182 participants of high demoralization (DS-MV > 30) and low demoralization (DS-MV 30) were obtained respectively, for a total of 364 participants. Results: Cancer patients' demoralization was significantly related to family support (p = .019), education (p = .049), and monthly income (p = .001). Family support [odds ratio = 0.38; p = .028; 95% confidence interval (0.16, 0.91)] and monthly income [odds ratio = 0.49; p = .009; 95% confidence interval (0.29, 0.84)] were protective factors of demoralization in cancer patients. Conclusion: Early and appropriate demoralization assessment of cancer patients' demographic and disease characteristics is very important in clinical settings. Healthcare providers might regularly monitor demoralization in cancer patients, and develop related nursing care guidelines or treatment for demoralization in cancer patients. The study results can be a reference for healthcare providers who work with cancer patients.
-
Yu-Cheng Chang,Shuo-Hsiu Wu 한국공업화학회 2019 Journal of Industrial and Engineering Chemistry Vol.76 No.-
Bi-functional Al-doped ZnO@SnO2 heteronanowires systematically analyzed as high-performancesubstrates for photocatalytic and surface-enhanced Raman scattering (SERS) applications. For thephotocatalytic application, the Al-doped ZnO@SnO2 heteronanowires can exhibit highly efficient andreusable photocatalysts in the photodecomposition of rhodamine 6G solution under low-powered UVlightirradiation, which ascribed to improve the inhabitation of electron–hole pairs recombination andhigher surface active sites. For the SERS application, Al-doped ZnO@SnO2 heteronanowires revealedsuitable geometry to deposit Ag nanoparticles with higher density and more hot spots in threedimensionalstructures, which can provide high SERS enhancement, low detection limit (amoxicillin10 10 M), high reproducibility, and stability.
-
Yu-Chi Li,Yin-Hsun Feng,Hui-Ying Chiang,Shu-Ching Ma,Hsiu-Hung Wang 한국간호과학회 2020 Asian Nursing Research Vol.14 No.4
Purpose: The aim of the study was to determine the effectiveness of dignity therapy for end-of-lifepatients with cancer. Methods: This study used a quasi-experimental study design with a nonrandomized controlled trial. Dignity therapy was used as an intervention in the experimental group, and general visit was used in thecontrol group. Thirty end-of-life patients with cancer were recruited, with 16 in the experimental groupand 14 in the control group. Outcome variables were the participants' dignity, demoralization, anddepression. Measurements were taken at the following time points: pre-test (before intervention), posttest1 (the 7th day), and post-test 2 (the 14th day). The effectiveness of the intervention in the twogroups was analyzed using the generalized estimating equation, with the p value set to be less than .05. Results: After dignity therapy, the end-of-life patients with cancer reflected increased dignity significantly[b ¼ 37.08, standard error (SE) ¼ 7.43, Wald c2 ¼ 24.94, p < .001], whereas demoralization(b¼ 39.55, SE ¼ 6.42,Wald c2 ¼ 37.95, p < .001) and depression (b¼ 12.01, SE ¼ 2.17,Wald c2 ¼ 30.71,p < .001) were both reduced significantly. Conclusion: Clinical nurses could be adopting dignity therapy to relieve psychological distress andimprove spiritual need in end-of-life patients with cancer. Future studies might be expanded tolooking at patients vis- a-vis end-of-life patients without cancer to improve their psychologicaldistress. These results provide reference data for the care of end-of-life patients with cancer fornursing professionals.
-
연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
